Upgrade to SI Premium - Free Trial

Scholar Rock Holding Corp. (SRRK)

41.49 -0.47 (1.12%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/10/26)

Latest Headlines

Truist Securities Reiterates Buy Rating on Scholar Rock (SRRK) After KOL Feedback October 20, 2026 9:24 AM - StreetInsider Scholar Rock to Report Third Quarter 2026 Financial Results on November 10, 2026 October 20, 2026 8:00 AM - BizWire U.S. biotech SMids: Q3 earnings preview October 18, 2026 8:00 PM - StreetInsider Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) October 16, 2026 4:15 PM - BizWire Truist Securities Reiterates Buy Rating on Scholar Rock (SRRK) October 13, 2026 9:03 AM - StreetInsider Raymond James Reiterates Strong Buy Rating on Scholar Rock (SRRK) October 8, 2026 9:51 AM - StreetInsider Scholar Rock resubmits SMA drug application to European regulators October 8, 2026 8:01 AM - StreetInsider Scholar Rock Resubmits Apitegromab Marketing Authorisation Application (MAA) to European Medicines Agency (EMA) for Treatment of Children and Adults with Spinal Muscular Atrophy (SMA) October 8, 2026 8:00 AM - BizWire Form 144 Scholar Rock Holding Filed by: Peng Katie October 1, 2026 4:20 PM - SEC Filing Form 4 Scholar Rock Holding For: Sep 24 Filed by: Woods Keith September 25, 2026 4:12 PM - SEC Filing Piper Sandler on Scholar Rock (SRRK): 'Survey Supports Broad ISEMBYLD Uptake' September 25, 2026 8:23 AM - StreetInsider Scholar Rock (SRRK) PT Raised to $77 at Truist Securities September 24, 2026 6:59 AM - StreetInsider Form 4 Scholar Rock Holding For: Sep 21 Filed by: Hallal David September 23, 2026 4:36 PM - SEC Filing Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) September 21, 2026 12:00 PM - BizWire Scholar Rock (SRRK) PT Raised to $70 at JPMorgan September 21, 2026 6:31 AM - StreetInsider UBS Reiterates Buy Rating on Scholar Rock (SRRK) September 15, 2026 9:16 AM - StreetInsider Form 8-K Scholar Rock Holding For: Sep 15 September 15, 2026 8:31 AM - SEC Filing Scholar Rock (SRRK) PT Raised to $75; Piper Sandler: 'Buying the Dip' September 15, 2026 7:37 AM - StreetInsider Scholar Rock (SRRK) PT Raised to $70 at H.C. Wainwright September 15, 2026 7:20 AM - StreetInsider Barclays Downgrades Scholar Rock (SRRK) to Equalweight September 15, 2026 3:49 AM - StreetInsider TD Cowen Reiterates Buy Rating on Scholar Rock (SRRK) September 14, 2026 12:20 PM - StreetInsider Scholar Rock (SRRK) PT Raised to $70 at Wedbush September 14, 2026 10:44 AM - StreetInsider Form 8-K Scholar Rock Holding For: Sep 11 September 14, 2026 8:00 AM - SEC Filing Premarket movers: AI stocks slide on warnings, Rumble, Scholar Rock jump September 14, 2026 7:45 AM - StreetInsider Scholar Rock (SRRK) PT Raised to $76 at Truist Securities September 14, 2026 5:56 AM - StreetInsider Scholar Rock (SRRK) PT Raised to $72 at Raymond James September 14, 2026 5:35 AM - StreetInsider Scholar Rock (SRRK) PT Raised to $74 at Citi September 14, 2026 4:16 AM - StreetInsider FDA approves Scholar Rock's ISEMBYLD for spinal muscular atrophy September 11, 2026 6:25 PM - StreetInsider Scholar Rock Announces FDA Approval of ISEMBYLD™ (apitegromab-mstn), the First and Only Muscle-Targeted Treatment for Children and Adults with Spinal Muscular Atrophy (SMA) September 11, 2026 6:25 PM - BizWire BMO Capital Reiterates Outperform Rating on Scholar Rock (SRRK) September 10, 2026 9:37 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Scholar Rock (SRRK) September 8, 2026 7:53 AM - StreetInsider Scholar Rock gets FDA fast track for apitegromab in rare muscle disease September 2, 2026 8:02 AM - StreetInsider Scholar Rock to Present at Upcoming Investor Conferences August 27, 2026 8:00 AM - BizWire BMO Capital Reiterates Outperform Rating on Scholar Rock (SRRK) August 24, 2026 9:28 AM - StreetInsider Scholar Rock updates apitegromab regulatory status in U.S., Europe, Japan August 21, 2026 9:06 AM - StreetInsider Scholar Rock Provides Update on Global Apitegromab Regulatory Progress Across U.S., Europe, and Japan August 21, 2026 9:06 AM - BizWire Form SCHEDULE 13G/A Scholar Rock Holding Filed by: Redmile Group, LLC August 14, 2026 4:24 PM - SEC Filing Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 14, 2026 4:15 PM - BizWire Form SCHEDULE 13G/A Scholar Rock Holding Filed by: Invus Global Management, LLC August 13, 2026 11:04 AM - SEC Filing Scholar Rock (SRRK) PT Raised to $63 at JPMorgan August 13, 2026 9:08 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Scholar Rock (SRRK) August 10, 2026 6:41 AM - StreetInsider Scholar Rock Announces FDA Review of Apitegromab Biologics License Application (BLA) for Spinal Muscular Atrophy (SMA) to Progress with Second Fill-Finish Facility; Approval Decision Anticipated by Se August 7, 2026 4:20 PM - BizWire Scholar Rock (SRRK) PT Raised to $76 at BMO Capital August 7, 2026 8:21 AM - StreetInsider Form 8-K Scholar Rock Holding For: Aug 06 August 6, 2026 8:50 AM - SEC Filing Form 424B5 Scholar Rock Holding August 6, 2026 8:47 AM - SEC Filing Scholar Rock Holding Corp. (SRRK) Tops Q2 EPS by 1c August 6, 2026 7:40 AM - StreetInsider Form 10-Q Scholar Rock Holding For: Jun 30 August 6, 2026 7:21 AM - SEC Filing Form 8-K Scholar Rock Holding For: Aug 06 August 6, 2026 7:10 AM - SEC Filing Scholar Rock Reports Second Quarter 2026 Financial Results and Recent Business Highlights August 6, 2026 7:00 AM - BizWire Scholar Rock to Present at the Canaccord Genuity 46th Annual Growth Conference July 29, 2026 8:00 AM - BizWire Full Article List